Michael Norden MD
Paul Herscu ND, MPH
Herscu Laboratory
Paul Herscu ND, MPH
Herscu Laboratory
The rapid emergence of superbugs, resistant to essentially all drugs, threatens to return us to the horrors of the pre-antibiotic era, where countless people died from common infections. The answer to this crisis may eventually come from advances in biotechnology, which ironically helped create the problem to begin with, but until that day, we would like to propose an ancient approach as a potential answer. Here, I condense a 4-year conversation I have had with my friend Michael Norden MD, involving copper, which reflects part of my 40-year interest in this element. What follows are our thoughts on using copper as a passive yet potent antibacterial.
Some of the most
exciting aspects of living in these times are the rapid discoveries occurring
in science, related to our habitat in the natural world and especially on the
cellular and subcellular level. As we are discovering more and more types of
germs, we are having to come to terms with the implications of our discoveries.
There are more types of germs than we ever imagined; the germs that surround us
and are in us determine to a significant extent, our health. Regarding
prevention, the concept of developing an individual vaccine for a specific germ
soon becomes unwieldy, as it seems impractical to vaccinate ourselves against
hundreds or thousands of potentially pathogenic bugs. Even the common influenza
vaccine sometimes fails us. For example, this year, vaccine manufacturers predicted
incorrectly and the vaccine developed appears to be only 10 to 20% effective.
Regarding treatment, we have learned that we can not simply kill infectious
agents, because germs adapt to become more virulent. The rapid and ubiquitous
use of antimicrobials has led to superbugs
threatening our therapeutic efficacy and creating dire challenges to our
species. We often lose the battle with germs that perhaps we should not be
fighting in the current manner in first place. Instead of active antimicrobial
use, and instead of prevention solely by developing a specific vaccine for each
germ, we may need to develop a third wave of thought, one focusing on passive
antimicrobial coatings that do not create superbugs,
which is where copper stands as one possibility.
The EPA has now
certified over 400 alloys as “antimicrobial copper.” Certification allows the
claim of 99.9% of bacteria will be killed within 2 hours. Published studies show this efficacy against all types of pathologic microbes including resistant
bacteria such as MRSA as well as many viruses and fungi. Microorganisms tested succumb to the copper effect.
What are the Potential Advantages of
Antimicrobial Copper?
Safety: With a 5,000-year history of use, copper should offer few
surprises. As a primary constituent of coins and water pipes for millennia,
lack of human toxicity is well established. Moreover, with hundreds of millions
of years of shared history with copper, microbes have not readily developed
resistance to copper’s killing impact. It seems unlikely that a strategic intentional use of copper will
change that.
Cost: The economic case for copper looks strong. Any reductions
in acquired infections will translate into substantial savings. Moreover, there
is the potential of slashing costs more than an order of magnitude by using
copper foil adhesives or a small amount of copper added to paints applied
especially in medical settings for equipment and touch surfaces. Importantly,
there is a net environmental benefit, as using this tiny amount of copper
offsets a great amount of medical waste.
Speed of Implementation: A number of companies now offer various
medical products utilizing EPA-certified antimicrobial copper. In the case of
copper foil adhesives, these are apparently ready to ship in whatever size and
quantity required, and this compact and relatively light cargo is appropriate
for air shipment. Installation takes less than a day and requires minimal
labor.
Visual Reinforcement of Hygiene: While antimicrobial copper alloys come
in a range of colors including the same silver color as the American quarter,
it may be helpful to use copper colored surfaces as both visual reassurance
that the facility is providing relatively safe touch surfaces, and a reminder
to be careful and wash hands –
especially if touching non-copper surfaces.
Cheap and practical water purification: Clean water is of vital importance
everywhere and often a challenge in developing countries. A simple copper coil
in a vessel of water for 12 hours renders it safe to consume and does not introduce significant
levels of copper into the water.
Third
Wave Concepts
For me, the most important advantages, what I term a
Third Wave rationale, gives us three invaluable attributes: Broad Range Application, Passive Practicality, and Continuous Action.
Broad
Range Efficacy: Unlike many other antimicrobial approaches, it is well
established that copper has the ability to quickly kill a wide range of
viruses, bacteria, and fungi. Evidence also confirms drastic reduction of bioburden. Recent studies have now begun to show
that this translates into substantial reductions in acquired infection.
Taking Ebola virus as an example, is
copper effective against Ebola virus?
Although no disinfectant is specifically established to kill Ebola virus, the
CDC guidelines suggest using ones that kill similar viruses, and copper meets
their guideline. Antimicrobial copper has been shown to inactivate the two
major types of viruses: those with and without a viral envelope. Ebola virus
and Influenza A are negative sense single-stranded RNA viruses, both with an
envelope protecting the viral genome. Thus, since copper inactivates Influenza A, because of
their similar characteristics there is good basis to assume, and to test,
whether copper may also inactivate Ebola virus.
Passive Practicality: A key consideration is that this is a passive technology. This approach has
distinct advantages not just in the USA, but in the developing world. There is
no training required for staff and no maintenance needed other than routine
cleaning. This passive approach is not dependent on electricity, adherence to
protocol, or any other human behavior or error. The remarkable challenge of
simply getting staff to wash their hands illustrates the importance of this
aspect even in top Western facilities.
Continuous Action: Most other approaches are only active when
applied and leave surfaces unprotected in the intervals between applications,
subject to recontamination. In the case of something like Ebola virus, where as
little as one virion may cause infection, this continuous action critically
allows copper to more readily eliminate all microbes.
Superbugs
What are
the implications concerning Superbugs? There
is increasing concern about infectious germs developing resistance to common
disinfectants. Moreover, there is startling evidence that disinfectants may
simultaneously promote the development of antibiotic resistance. One study
showed that a commonly used disinfectant made Pseudomonas aeruginosa 256 times more resistant to the widely
prescribed antibiotic Ciprofloxacin – even though the bacteria had never been exposed to it. The European Commission concurs that,
“the use or misuse of certain active substances in biocidal products in various
settings, may contribute to the increased occurrence of antibiotic resistant bacteria, both in humans
and animals.
In stark
contrast, antimicrobial copper alloys are unlikely to promote resistance. There
are a few organisms that show higher tolerance to copper, but despite human use
of copper and copper alloys for thousands of years, “no bacteria fully
resistant to contact killing has been discovered.” The reasons for this include that:
“transfer of genetic determinants from antibiotic-resistant microbes is
dramatically reduced on copper alloyed surfaces through the destruction of the nucleic acid within the microbes in contact with the
copper surfaces, and also “contact killing is very rapid, and cells are not dividing on copper surfaces.”
Mechanism of Action
It is not
completely clear why copper is so effective in this role. The prevailing
thought is that there are numerous pathways that copper uses to kill germs, all
working together to achieve this impact. For example, I believe there is a biphasic nature to copper. At low doses copper helps bugs
grow, and at higher doses, it disturbs many cell structures, forming free radicals, oxygen species, oxidative stress, which kills germs. In addition, copper damages cell walls,
allowing internal contents to leak out of the cell, thereby drying out the
germ.
Clinical Outcomes
Are there clinically important outcomes? A recent publication reported the results
of a 7.7 million dollar trial, under contract with the Department of Defense,
conducted at 3 medical centers, including Memorial Sloan-Kettering in New York
City. It found a greater than 80% reduction of microbes present on surfaces in
ICU rooms outfitted with copper on six frequently touched surfaces. Over the
2-year period of the trial, antimicrobial efficacy was maintained with no
interventions other than routine cleaning. The microbial burden on critical
surfaces was kept at levels typically achieved after terminal cleaning. The
trial further established this reduction in bioburden, was associated with a
58% reduction in acquired infections.
Furthermore, an
Israeli study in a long-term head injury unit using only copper infused linens
and clothing, similarly showed a 24% reduction in Hospital Acquired Infections
(HAI) and a 46% decrease in fever days. There is potential for even greater
effect if antimicrobial copper surfaces and copper infused linens and clothing
are used simultaneously.
Need for more data:
1) More data is
needed to test if antimicrobial copper consistently reduces bioburden and if that reduction will translate
into reduced HAI.
2) Evidence of
specific effectiveness against Ebola virus would be extremely helpful. This
should be fast and inexpensive if a sanctioned laboratory agrees to conduct a
trial. Publicity generated around findings would raise awareness of the
potential of Third Wave concepts of passive antimicrobial touch surface
technology, such as copper, as suggested here.
What can Research do to Help?
1) Continue to
study effects of antimicrobial copper in terms of mortality, morbidity, and
economic impact.
2) Test copper
specifically against particular contact germs, such as Ebola virus.
3) Provide
copper equipment copper foil adherents or copper infused paints to treatment
centers, if not in the USA, then in developing countries. Study impact of
centers thus equipped in contrast to similar centers to test in-field proof of
concept.
As I sit and
write this, I am cognizant of a few populations particularly vulnerable. Hospital
acquired infections remain a major concern. Having at least some touch surfaces
become passively germ-free may offer some protection. For example, can anyone
actually justify why is it that door handles are made of metals that let germs
survive, passing from person to person as we touch that surface, instead of
having that surface passively clean itself? Stainless steel does not kill
germs. You have to constantly and actively
clean that surface, a virtual impossibility. This rationale is also true in
rehabilitation facilities and geriatric care homes. There are a half dozen
surfaces that if changed to copper would lower bioburden dramatically. Lastly, developing
countries may not be able to afford expensive equipment or expensive training
of skilled personnel to use that equipment. It may be difficult to keep
appropriate disinfecting supplies in stock. Generating data here would
demonstrate low cost, high yield technology suitable in developing countries.
This remains true for the nationals that live and work in that country or to
the medical missionaries that travel to assist in health care delivery.
As we come to
terms with the reality of germs outside of and within us, it is time to consider,
not just killing germs in an active manner, which unfortunately leads to
resistance and superbugs. It is time
to think about not just preventing illness one germ at a time as with
vaccinations, but rather, learning to limit the bioburden without accelerating
evolutionary resistant strains, using a more passive method. Copper may just be
one winning candidate, where the technology is affordable, understood and easy
to implement. This approach potentially can save countless lives without any
other innovation needed.